Would you hold rituximab for newly diagnosed B-cell lymphoma if the patient is COVID-19 positive?  

The question of how best to manage ongoing lymphoma therapy in the face of SARS-CoV-2 infection remains unanswered. That said, centers are developing guidance for clinicians based upon available and emerging data. Newer data from MSKCC suggest that recent treatment (within the last 30 days) is not ...